This company listing is no longer active
TCR2 Therapeutics Management
Management criteria checks 3/4
TCR2 Therapeutics' CEO is Garry Menzel, appointed in Jan 2016, they has a tenure of 6.67 years. Their total yearly compensation is $1.90M , comprised of 30.4% salary and 69.6% bonuses, including company stock and options. They directly owns 0.69% of the company’s shares, worth €656.23K. The average tenure of the management team and the board of directors is 2 years and 3.1 years respectively.
Key information
Garry Menzel
Chief executive officer
US$1.9m
Total compensation
| CEO salary percentage | 30.4% |
| CEO tenure | 6.7yrs |
| CEO ownership | 0.7% |
| Management average tenure | 2yrs |
| Board average tenure | 3.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$115m |
| Mar 31 2022 | n/a | n/a | -US$107m |
| Dec 31 2021 | US$2m | US$580k | -US$100m |
| Sep 30 2021 | n/a | n/a | -US$91m |
| Jun 30 2021 | n/a | n/a | -US$81m |
| Mar 31 2021 | n/a | n/a | -US$73m |
| Dec 31 2020 | US$6m | US$560k | -US$67m |
| Sep 30 2020 | n/a | n/a | -US$61m |
| Jun 30 2020 | n/a | n/a | -US$58m |
| Mar 31 2020 | n/a | n/a | -US$53m |
| Dec 31 2019 | US$8m | US$492k | -US$97m |
| Sep 30 2019 | n/a | n/a | -US$96m |
| Jun 30 2019 | n/a | n/a | -US$100m |
| Mar 31 2019 | n/a | n/a | -US$107m |
| Dec 31 2018 | US$3m | US$436k | -US$62m |
| Sep 30 2018 | n/a | n/a | -US$55m |
| Dec 31 2017 | US$792k | US$423k | -US$15m |
Compensation vs Market: Garry's total compensation ($USD1.90M) is above average for companies of similar size in the German market ($USD410.59K).
Compensation vs Earnings: Garry's compensation has been consistent with company performance over the past year.
CEO
Garry Menzel (58 yo)
6.7yrs
Tenure
US$1,904,534
Compensation
Dr. Garry E. Menzel, Ph D., M.B.A. serves as an Independent Director at Black Diamond Therapeutics, Inc. since March 2017. He serves as Director at Stoke Therapeutics, Inc since August 17, 2020.He serves...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.7yrs | US$1.90m | 0.69% $ 656.2k | |
| Founder & Member of the Advisory Board | no data | US$47.02k | no data | |
| Chief Technical Officer | 1.2yrs | US$2.74m | 0.0057% $ 5.4k | |
| Chief Medical Officer | 5.7yrs | US$1.04m | 0.12% $ 116.0k | |
| Vice President of Corporate Controller | less than a year | no data | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior Director of Investor Relations & Corporate Communications | no data | no data | no data | |
| Head of Legal & Corporate Secretary | 4.7yrs | no data | no data | |
| Chief People Officer | 2.9yrs | no data | 0.025% $ 24.0k | |
| Chief Business & Strategy Officer | less than a year | no data | no data |
2.0yrs
Average Tenure
48yo
Average Age
Experienced Management: 2K7's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 6.7yrs | US$1.90m | 0.69% $ 656.2k | |
| Founder & Member of the Advisory Board | less than a year | US$47.02k | no data | |
| Independent Director | 7.3yrs | no data | no data | |
| Independent Director | 4.6yrs | US$92.52k | 0% $ 0 | |
| Chairman of Advisory Board | no data | US$18.75k | no data | |
| Independent Chairman of the Board | 2.3yrs | US$89.08k | 0% $ 0 | |
| Independent Director | 3.8yrs | US$86.58k | 0% $ 0 | |
| Independent Director | 2.4yrs | US$78.08k | 0% $ 0 | |
| Independent Director | 1.6yrs | US$405.41k | 0% $ 0 | |
| Member of Advisory Board | no data | no data | no data | |
| Member of the Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data |
3.1yrs
Average Tenure
63yo
Average Age
Experienced Board: 2K7's board of directors are considered experienced (3.1 years average tenure).